MUFG Americas’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

MUFG Americas’s Portfolio AXN Stock Details AXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,610	Closed	-$2K	–	1239
2016 Q1	$2K	Sell	3,610 -2,480	-41%	-$1.83K	﹤0.01%	1128
2015 Q4	$4K	Buy	+6,090	New	+$7.65K	﹤0.01%	974

Other funds holding AXN

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MUFG Americas's AXN Position: Q2 2016 in Review

MUFG Americas sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q2 2016, closing a stake of 3,610 shares — an estimated $2K sold.

MUFG Americas first reported a position in AXN in Q4 2015 and held it in 2 quarters. The position peaked at $4K in Q4 2015. 11 funds tracked by Wall St. Rank hold AXN as of Q2 2016.

MUFG Americas reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q2 2016 after selling out during the quarter.
MUFG Americas sold 3,610 Aoxing Pharmaceutical Company Inc. shares in Q2 2016, an estimated $2K.
MUFG Americas first reported a position in Aoxing Pharmaceutical Company Inc. in Q4 2015 and held it in 2 quarters.
MUFG Americas's Aoxing Pharmaceutical Company Inc. position peaked at $4K in Q4 2015.
11 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q2 2016.

Based on MUFG Americas's 13F filing for Q2 2016, filed 8 Aug 2016.